First Report Customer Care 
All time: 4.6

Latest / Last 30 Days: 5.0

528 Reviews

Credit Rating - PHARMIDEX PHARMACEUTICAL SERVICES LIMITED

ANALYSIS
Credit Risk Update: SECURED CREDITOR INFORMATION: PHARMIDEX PHARMACEUTICAL SERVICES LIMITED, 3rd Floor 14 Hanover Street, London, W1S 1YH. The legal status is a Private Limited Company and the current status at the registry of companies is Active. The last filed accounts are dated 31 December 2022. The company was incorporated on 17 May 2002.

The accounts next due date is 30 September 2024. There are 8 mortgages, 7 satisfied, none part satisfied and 1 unsatisfied.

The above was based on public record information as at 2 February 2025 and may not reflect the current status. Please access the current report to ascertain the current status and credit rating.
SUMMARY
Registered Number: 04441512
Date Incorporated: 17 May 2002
Date Latest Accounts: 31 December 2022
BUSINESS INFORMATION
Legal Form: Private Limited Company
Previous Names: None
Registered Number: 04441512
Annual Return: 17 May 2016
Registered Office: 3rd Floor 14 Hanover Street, London, W1S 1YH
SIC Code and Operations: 72110
SECURED CREDITORS
Number of Mortgages 8
Satisfied Mortgages 7
Part Satisfied Mortgages 0
Unsatisfied Mortgages 1
CREDIT RISK RATING
This is the credit risk assessment used by one of the top UK credit reference agencies.
Risk Score (1-100):

PHARMIDEX PHARMACEUTICAL SERVICES LIMITED

Click Here

to view this information

Risk Assessment:
Credit Rating:



First Report Score: (0-10):

Financial Status Guide:
10  trafficlight Very Strong
9   Strong
8 Very Good
7 Good
6 Above Average
5 Average
4 Below Average
3 Poor
2 Weak
1 Very Weak
0 Critical
Report Created On 12 February 2025 Copyright © 2025 First Report Ltd


Recent Searches

Reg No. Reg Name Status
11384396 PHARMIDEX PNEUMOLABS LIMITED Dissolved
15340889 PHARMIE LTD. Active
09395198 PHARMIER CONSULT LIMITED Active - Proposal to Strike off
14617204 PHARMIFY LTD Active
13966129 PHARMIFY RECRUITMENT LTD Active

In using this service you agree to the Terms and Conditions

© 2025 First Report Ltd